Abstract
An open study is reported in which 35 general practitioners treated 128 patients suffering from ‘Red Eye’ with a new eye ointment containing 10% Tanderil (oxyphenbutazone) and 1% chloramphenicol.
One hundred and seventeen patients completed the seven day treatment period, in which time 99 had complete resolution of the symptoms and were discharged, the remaining 18 patients needed a longer period of treatment.
Eleven patients failed to complete the study period, of whom 5 patients were subsequently referred to a specialist and 6 had their treatment changed by the general practitioner. Six patients showed signs of allergy to the ointment, all of whom were being treated for allergic conjunctivitis. Seventeen per cent of patients had some difficulty in applying the eye ointment or complained of subsequent blurring of vision.
Get full access to this article
View all access options for this article.